Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-24
1999-04-06
Jarvis, William R.A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, 514661, 514662, A61K 3144, A61K 31405, A61K 3113
Patent
active
058918850
ABSTRACT:
The migraine-treating effectiveness of an antimigraine drug is significantly enhanced by administering a selective 5-HT.sub.1 agonist together with dextromethorphan or dextrorphan.
REFERENCES:
patent: 4650810 (1987-03-01), Bays et al.
patent: 4914125 (1990-04-01), Baldinger et al.
patent: 4916125 (1990-04-01), Herrling et al.
patent: 4994484 (1991-02-01), Binder et al.
patent: 5021428 (1991-06-01), Carr et al.
patent: 5155218 (1992-10-01), Weinshank et al.
patent: 5200413 (1993-04-01), King et al.
patent: 5242949 (1993-09-01), Goldberg et al.
patent: 5248684 (1993-09-01), Suzuki et al.
patent: 5273759 (1993-12-01), Simmons
patent: 5317103 (1994-05-01), Baker et al.
patent: 5364863 (1994-11-01), Cohen et al.
patent: 5399574 (1995-03-01), Robertson et al.
patent: 5434154 (1995-07-01), Smith et al.
patent: 5436255 (1995-07-01), Butler
patent: 5441969 (1995-08-01), Axelsson et al.
patent: 5464864 (1995-11-01), King et al.
patent: 5466699 (1995-11-01), Robertson et al.
patent: 5468768 (1995-11-01), Cipollina et al.
patent: 5491148 (1996-02-01), Berger et al.
patent: 5494910 (1996-02-01), North et al.
patent: 5502058 (1996-03-01), Mayer et al.
"Intranasal Lidocaine for Treatment of Migraine", Maizeis et al., JAMA, Jul. 24/31, 1996, vol. 276, No. 4, p. 319-321.
"The Pharmacology of Current Anti-Migraine Drugs", Peroutka, Headache, Jan. 1990, vol. 30, pp. 5-11.
"Drugs and the Treatment of Migraine", Peatfield, Trends. Pharmacol. Sci., Apr. 1988, vol. 9, pp. 141-145.
"Drugs Used to Treat Migraine and Other Headaches", Drug Evaluators, American Medical Associations, 1986, 6th Edition, Chapter 13, pp. 239-252.
Dhavare, et al. "Effect of Drugs Influencing Central 5-Hydroxytryptamine Mechanisms on Amantadine-Induced Sterotyped Behaviour in the Rat", Indian Journal Physiol.Pharmacol., vol. 27 No. 1, 1983, pp. 19-24.
Maj. et al "Antagonistic Effect of Cyproheptadine on Neuroleptic-Induced Catalepsy", Pharmacology Biochemistry and Behaviour, vol. 3, No. 1, 1975, pp. 25-27.
Skuza et al., "Memantine, Amantadine, and L-Deprenyl Pontentiate the Action of L-DOPA in Monoamine-Depleted Rats", Journal of Neural Transmission, vol. 98, No. 1, 1994, pp. 57-67.
Rabey et al, "Selective Regional Effect of Various Neuroactive Drugs on Bromocriptine Concentration in the Brain of Rats", Acta Neurol. Scand., vol. 74, No. 4, 1986, pp. 289-292.
Hof et al, "Mutual Inhibition and Synergistic Effects of Ergotamine and the Calcium Antagonist Darodipine", Gen Pharmacol., vol. 17, No. 3, 1986, pp. 309-314.
Bartoli, et al "Does Lidocaine Affect Oxidative Dextromethorphan Metabolism In Vivo?", Giorn. Ital. Chim. Clin., vol. 18, No. 2, 1993, pp. 125-129.
Algos Pharmaceutical Corporation
Jarvis William R.A.
LandOfFree
Method for treating migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating migraine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1371623